The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -11.08%. However, over
The market performance of Editas Medicine Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $6.69 on 05/15/24, while the lowest value for the same duration was $0.91 on 04/07/25. 52-week price history of
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Global Payments, Inc’s current trading price is -34.11% away from its 52-week high, while its distance from the 52-week low is 8.08%. The stock’s
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -64.56%. However, over the last six months,
Solid Biosciences Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $10.99 on 05/10/24, and the lowest price during the same period was recorded at $2.47 on 04/16/25. 52-week price history of SLDB Stock Analyzing the 52-week price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Paramount Group Inc’s current trading price is -23.77% away from its 52-week high, while its distance from the 52-week low is 11.20%. The stock’s price
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -9.09%. However, over the last six months,
Dr. Reddy’s Laboratories Ltd. ADR’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $16.89 on 08/09/24 and a low of $12.26 for the same time frame on 04/09/25. 52-week price history of RDY Stock A stock’s 52-week
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Xeris Biopharma Holdings Inc’s current trading price is -32.78% away from its 52-week high, while its distance from the 52-week
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -88.51%. However, over the last six months,
All rights reserved © 2024, Powered By Smart TechOne
